Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report

BACKGROUND: Clozapine is among the most effective antipsychotics used for treatment resistant schizophrenia. Adverse reactions to clozapine include neutropenia. In March 2020, at the start of the Coronavirus −19 pandemic, clinicians raised concerns regarding continuation of antipsychotic treatment,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonaccorso, Stefania, Ricciardi, Angelo, Ouabbou, Sophie, Theleritis, Christos, Ross-Michaelides, Arabella, Metastasio, Antonio, Stewart, Neil, Mohammed, Marwa, Schifano, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840406/
https://www.ncbi.nlm.nih.gov/pubmed/33527097
http://dx.doi.org/10.1016/j.bbih.2021.100212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840406/
https://www.ncbi.nlm.nih.gov/pubmed/33527097
http://dx.doi.org/10.1016/j.bbih.2021.100212

Ejemplares similares